Machine Learning Integration of In-Silico QSAR, Graph Neural Networks and Docking Reveal Natural Products Inhibitors Against Mycobacterium tuberculosis
Scientia Pharmaceutica · 14.05.2026 · 94 (2) · 39
DOI: 10.3390/scipharm94020039 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientia Pharmaceutica, online erschienen am 14.05.2026. Verfasst von Sakthidhasan Periasamy und 3 weiteren Autor:innen. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Tuberculosis (TB), caused by Mycobacterium tuberculosis, remains a major global health challenge, exacerbated by the emergence of multidrug-resistant strains and limited efficacy of existing therapies. Given the involvement of multiple essential mycobacterial proteins, multitarget drug discovery represents a rational therapeutic strategy.
Methods
In this study, an integrated in silico pipeline combining machine learning–based quantitative structure–activity relationship modeling, graph neural network–driven drug–target affinity prediction, molecular docking, molecular dynamics (MD) simulations, and pharmacokinetic–toxicity profiling was employed to identify potential antitubercular leads from natural products.
Results
A curated library of over 0.69 million compounds from the COCONUT database was systematically screened against seven essential M. tuberculosis protein targets. Machine learning and heterogeneous graph neural network models effectively captured complex ligand–protein interaction patterns, enabling high-confidence multitarget prioritization. Structure-based docking and MM-GBSA analyses revealed favorable binding affinities, further supported by 100 ns Molecular Dynamics simulations demonstrating stable binding and conformational integrity. In silico ADMET and toxicity predictions identified pharmacokinetically balanced candidates, while density functional theory calculations corroborated favorable electronic properties.
Conclusions
Notably, a myricetin-based flavonoid glycoside exhibited consistent multitarget binding and dynamic stability across all targets. Overall, this study underscores the potential of integrated artificial intelligence and structure-based approaches in accelerating natural product-based antitubercular drug discovery and supports further experimental validation of prioritized leads.
Zitieren
APA
Periasamy, S., Ramasamy, R., Chinnaiyan, R., & Sridhar, A. (2026). Machine Learning Integration of In-Silico QSAR, Graph Neural Networks and Docking Reveal Natural Products Inhibitors Against Mycobacterium tuberculosis. Scientia Pharmaceutica, 94(2), 39. https://doi.org/10.3390/scipharm94020039
Vancouver
Periasamy S, Ramasamy R, Chinnaiyan R, Sridhar A. Machine Learning Integration of In-Silico QSAR, Graph Neural Networks and Docking Reveal Natural Products Inhibitors Against Mycobacterium tuberculosis. Scientia Pharmaceutica. 2026;94(2):39. doi:10.3390/scipharm94020039
BibTeX
@article{Periasamy2026,
author = {Periasamy, Sakthidhasan and Ramasamy, Rajesh and Chinnaiyan, Rajasekar and Sridhar, Arun},
title = {Machine Learning Integration of In-Silico QSAR, Graph Neural Networks and Docking Reveal Natural Products Inhibitors Against Mycobacterium tuberculosis},
journal = {Scientia Pharmaceutica},
year = {2026},
volume = {94},
number = {2},
pages = {39},
doi = {10.3390/scipharm94020039}
}
EUVIMED